UnitedHealth Group Appoints Scott Gottlieb to Board of Directors
Reuters
Nov 22
UnitedHealth Group Appoints Scott Gottlieb to Board of Directors
UnitedHealth Group Inc. has announced the appointment of Scott Gottlieb, M.D. as an independent director on its Board of Directors, effective immediately. Dr. Gottlieb is a former FDA commissioner and currently serves as a director for Pfizer, Tempus AI, and Illumina. He has also held positions at the Centers for Medicare & Medicaid Services and the Federal Health Information Technology Policy Committee. Dr. Gottlieb has not yet been assigned to any board committees.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. UnitedHealth Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000731766-25-000314), on November 21, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.